Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Leninsky prospekt 33-2, Moscow, 119071, Russia.
Collaborations Pharmaceuticals, Inc., 840 Main Campus Drive, Lab 3510, Raleigh, NC27606, USA.
Eur J Med Chem. 2019 Sep 15;178:606-622. doi: 10.1016/j.ejmech.2019.06.008. Epub 2019 Jun 11.
The hydrophobic pocket within viral capsid protein 1 is a target to combat the rhino- and enteroviruses (RV and EV) using small molecules. The highly conserved amino acids lining this pocket enable the development of antivirals with broad-spectrum of activity against numerous RVs and EVs. Inhibitor binding blocks: the attachment of the virion to the host cell membrane, viral uncoating, and/or production of infectious virus particles. Syntheses and biological studies of the most well-known antipicornaviral capsid binders have been reviewed and we propose next steps in this research.
病毒衣壳蛋白 1 内的疏水性口袋是使用小分子对抗 rhino- 和肠病毒 (RV 和 EV) 的靶标。排列在这个口袋中的高度保守的氨基酸使开发具有广谱活性的抗病毒药物成为可能,能够对抗多种 RV 和 EV。抑制剂结合位点:病毒粒子与宿主细胞膜的附着、病毒脱壳和/或感染性病毒颗粒的产生。对最著名的抗小 RNA 病毒衣壳结合物的合成和生物学研究进行了综述,并提出了该研究的下一步措施。